Equities
Health CarePharmaceuticals & Biotechnology
  • Price (USD)49.87
  • Today's Change1.54 / 3.19%
  • Shares traded737.50k
  • 1 Year change-3.74%
  • Beta1.1992
Data delayed at least 15 minutes, as of Dec 04 2020 21:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by enabling consumers to proactively prevent or treat conditions that can be self-managed. The Company operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the United States (U.S.), Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with generic consumer-focused businesses in the United Kingdom (U.K.) and Australia. The Prescription Pharmaceuticals segment commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel.

  • Revenue in USD (TTM)5.10bn
  • Net income in USD-6.60m
  • Incorporated2013
  • Employees11.20k
  • Location
    Perrigo Company PLCThe Sharp Building, Hogan PlaceDUBLIN D02 TY74IrelandIRL
  • Phone+353 17094000
  • Websitehttps://www.perrigo.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PRGO:NYQ since
announced
Transaction
value
Sanofi SA-Eastern European OTC Skincare & Hair Loss Treatment Brands(3)Deal completed11 Aug 202011 Aug 2020Deal completed-3.61%--
High Ridge Brands Co-Oral Care AssetsDeal completed24 Feb 202024 Feb 2020Deal completed-16.69%113.00m
Data delayed at least 15 minutes, as of Dec 04 2020 21:10 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Brightview Holdings Inc2.35bn-41.60m1.45bn19.00k--1.1414.180.617-0.4016-0.401622.6312.130.782106.105.49123,473.70-1.39---1.59--25.38---1.77--1.391.700.4768---2.44---193.69------
WW International Inc1.39bn91.85m2.23bn17.00k25.03--15.851.611.311.3120.01-8.600.918921.0641.4481,604.706.097.748.0510.7555.5753.406.628.070.79072.021.620.00-6.66-0.9164-45.890.3087-1.48--
H & R Block Inc3.09bn244.62m3.51bn3.50k14.0225.948.441.141.301.2415.870.70130.7624--35.65882,968.006.0511.217.4316.6341.8243.817.9412.58--5.190.962853.23-14.71-3.03-98.76-59.17-7.885.39
Redfin Corp874.77m-43.16m5.26bn3.38k--12.86--6.01-0.47-0.478.924.391.2910.4726.70259,036.70-5.95---8.07--21.9124.24-4.61-9.722.33-3.470.29--60.1544.13-92.49--25.64--
Perrigo Company PLC5.10bn-6.60m6.81bn11.20k--1.1717.861.34-0.0566-0.056637.2542.640.44543.134.54455,053.60-0.0577---0.0653--35.84---0.1295--1.727.830.3795--2.23--11.53------
Service Corporation International3.39bn462.02m8.57bn16.32k19.504.9611.922.532.542.5418.6710.000.250395.7744.05207,843.203.412.603.572.7325.9223.1413.6310.390.54694.340.678634.111.271.53-14.2716.7610.6817.28
Bright Horizons Family Solutions Inc1.66bn72.09m10.05bn33.80k136.628.1554.876.061.221.2227.8620.360.4818--12.3949,071.892.105.412.446.4821.7324.914.357.58--3.600.45710.008.358.7914.1820.2511.06--
Expedia Group Inc7.03bn-2.20bn18.19bn25.40k--11.14--2.59-15.62-15.6249.3118.770.3422--3.99276,614.20-11.002.78-20.755.6472.2281.98-32.154.74---1.900.68134.257.5215.9339.167.2528.7114.87
Trip.com Group Ltd (ADR)3.32bn-343.49m20.83bn44.30k--1.38--6.27-0.7095-0.70955.1325.510.1081--2.8874,968.00-0.04091.49-0.06282.2577.6478.80-0.37818.79---2.400.3990.0015.1837.16530.4995.94-29.53--
Data as of Dec 04 2020. Currency figures normalised to Perrigo Company PLC's reporting currency: US Dollar USD

Institutional shareholders

45.84%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 202017.96m13.16%
The Vanguard Group, Inc.as of 30 Sep 202014.82m10.86%
BlackRock Fund Advisorsas of 30 Sep 20207.16m5.25%
SSgA Funds Management, Inc.as of 30 Sep 20206.34m4.65%
The London Company of Virginia LLCas of 30 Sep 20203.08m2.26%
Dimensional Fund Advisors LPas of 30 Sep 20202.88m2.11%
Camber Capital Management LPas of 30 Sep 20202.85m2.09%
Brown Brothers Harriman & Co. (Investment Management)as of 30 Sep 20202.64m1.93%
Franklin Mutual Advisers LLCas of 30 Sep 20202.48m1.82%
Geode Capital Management LLCas of 30 Sep 20202.35m1.72%
More ▼
Data from 30 Sep 2020 - 30 Sep 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.